J. Safra Sarasin Holding’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.35M Buy
49,685
+3,644
+8% +$243K 0.05% 194
2026
Q1
$2.89M Buy
46,041
+9,758
+27% +$680K 0.05% 163
2025
Q4
$2.41M Buy
36,283
+13,299
+58% +$860K 0.04% 187
2025
Q3
$1.55M Sell
22,984
-17,591
-43% -$1.39M 0.03% 240
2025
Q2
$3.54M Buy
40,575
+24,590
+154% +$1.93M 0.06% 155
2025
Q1
$1.09M Sell
15,985
-19,590
-55% -$1.6M 0.02% 304
2024
Q4
$2.77M Sell
35,575
-44,836
-56% -$3.32M 0.05% 182
2024
Q3
$5.39M Buy
80,411
+25,738
+47% +$2.11M 0.09% 132
2024
Q2
$6.2M Buy
+54,673
New +$6.91M 0.11% 126

Other funds holding DXCM

J. Safra Sarasin Holding's DXCM Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its DexCom (DXCM) stake by 7.9% in Q2 2026, buying an estimated $243K and bringing the position to 49,685 shares worth $3.35M. The position accounts for 0.05% of the portfolio, ranked #194.

J. Safra Sarasin Holding first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.2M in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • J. Safra Sarasin Holding held 49,685 shares of DexCom worth $3.35M as of Q2 2026.
  • J. Safra Sarasin Holding bought 3,644 DexCom shares in Q2 2026, an estimated $243K.
  • DexCom made up 0.05% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #194 holding.
  • J. Safra Sarasin Holding first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's DexCom position peaked at $6.2M in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.